LipoAgent: Coordinating Fine-Tuned LLM Agents for Safer Lipid Design
LipoAgent is a new framework designed to enhance the safety and efficiency of lipid nanoparticles for nucleic acid delivery. By integrating multi-agent coordination and toxicity considerations, it aims to improve the design process for lipids. The framework has shown a significant improvement in mRNA transfection efficiency predictions compared to existing models.
- ▪LipoAgent combines domain-specific fine-tuning with a conditional prediction objective to prioritize safety in lipid design.
- ▪The framework achieved an average 32% relative improvement in mRNA transfection efficiency prediction across multiple foundation models.
- ▪Wet-lab validation confirms that the virtual screening rankings from LipoAgent translate reliably to biological transfection outcomes.
Opening excerpt (first ~120 words) tap to expand
Computer Science > Artificial Intelligence arXiv:2605.25250 (cs) [Submitted on 24 May 2026] Title:LipoAgent: Coordinating Fine-Tuned LLM Agents for Safer Lipid Design Authors:Leshu Li, An Lu, Haiyu Wang, Zhibin Feng, Conghui Duan, Qing Bao, Zongmin Zhao, Sai Qian Zhang View a PDF of the paper titled LipoAgent: Coordinating Fine-Tuned LLM Agents for Safer Lipid Design, by Leshu Li and 7 other authors View PDF HTML (experimental) Abstract:Lipid nanoparticles (LNPs) are among the most clinically mature platforms for nucleic acid delivery, yet designing lipids that are both effective and biologically safe remains a major bottleneck. In practical screening, toxicity is a decision-level constraint: if a lipid is toxic, its efficiency prediction is clinically irrelevant.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at arXiv cs.AI.
Discussion
0 commentsMore from arXiv cs.AI
